文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

抗血小板和抗凝药物对老年平地跌倒患者颅脑损伤发生率、手术及死亡率影响甚微:33,710例多中心分析

Antiplatelet and anticoagulant agents have minimal impact on traumatic brain injury incidence, surgery, and mortality in geriatric ground level falls: A multi-institutional analysis of 33,710 patients.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论老年平地跌倒患者中,抗血栓药物使用与TBI风险关系不一致,但未显著增加死亡率,可能对临床管理影响甚微。

该多中心回顾性研究纳入90家医院创伤登记中≥65岁平地跌倒患者33,710例,排除除头部外其他区域AIS>2者,按伤前抗血栓药物方案分为无、单药或多药组,比较TBI诊断率、TBI手术率和死亡率。结果示无抗血栓组TBI率21.25% vs 抗血栓组21.61%(p=0.418);阿哌沙班(15.7%,p<0.001)和利伐沙班(13.19%,p=0.011)与较低TBI率相关,阿司匹林-氯吡格雷与较高TBI率相关(24.34%,p=0.002);阿司匹林-氯吡格雷颅脑手术率2.9% vs 无抗血栓组1.96%(p=0.006),其他方案手术率相似;无任何方案与更高死亡率相关。作者认为抗血栓药物对临床管理影响可能可忽略,需大型前瞻性研究确认。

要点

  • 无抗血栓组TBI诊断率21.25% vs 抗血栓组21.61%(p=0.418),两组无显著差异。
  • 阿哌沙班(15.7%,p<0.001)和利伐沙班(13.19%,p=0.011)与较低TBI率相关,阿司匹林-氯吡格雷与较高TBI率相关(24.34%,p=0.002)。
  • 阿司匹林-氯吡格雷颅脑手术率2.9% vs 无抗血栓组1.96%(p=0.006),其他方案手术率相似。
  • 无任何抗血栓方案与更高死亡率相关。
  • 抗血栓药物对老年平地跌倒后TBI风险影响不一致,未显著增加死亡率,可能对临床管理影响甚微。

适用人群与场景

  • ≥65岁平地跌倒患者,来自90家医院创伤登记;排除<65岁或除头部外其他区域简明损伤定级(AIS)评分>2者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心回顾性分析,纳入90家医院创伤登记中33,710例≥65岁平地跌倒患者(35%男性;平均年龄80.5岁;平均GCS 14.6),47.6%使用单药或联合抗血栓治疗。
  • 主要终点:无抗血栓组TBI诊断率21.25% vs 抗血栓组21.61%(p=0.418),无显著差异。
  • 阿哌沙班TBI率15.7%(p<0.001)、利伐沙班13.19%(p=0.011)低于无抗血栓组;阿司匹林-氯吡格雷TBI率24.34%(p=0.002)高于无抗血栓组。
  • 阿司匹林-氯吡格雷颅脑手术率2.9% vs 无抗血栓组1.96%(p=0.006);其他方案手术率与无抗血栓组相似。
  • 无任何抗血栓方案与更高死亡率相关。

证据类型、等级与局限

  • 证据类型:多中心回顾性分析(基于创伤登记),证据等级:治疗/临床管理,level II。
  • 局限:原文未述局限性。

对床旁实践的改变

  • 原文结论提示抗血栓药物使用可能对老年平地跌倒患者临床管理影响甚微,但原文同时指出需大型前瞻性研究确认,未给出具体实践推荐。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Falls are the leading cause of traumatic brain injury (TBI) and TBI-related deaths for older persons (age, ≥65 years). Antiplatelet and/or anticoagulant therapy (antithrombotics [ATs]) is generally felt to increase this risk, but the literature is inconsistent. The purpose of this study was to determine the impact of AT use on the rate, severity, and outcomes of TBI in older patients following ground level falls.

METHODS: Ground level fall patients from 90 hospitals' trauma registries were selected. Patients were excluded if younger than 65 years or had an Abbreviated Injury Scale score of >2 in a region other than head. Electronic medical record data for preinjury AT therapy were obtained. Patients were grouped by regimen for no AT, single, or multiple agents. Groups were compared on rates of diagnosed TBI, TBI surgery, and mortality.

RESULTS: There were 33,710 patients (35% male; mean age, 80.5 years; mean Glasgow Coma Scale, 14.6), with 47.6% on single or combination AT therapy. The proportion of patients with TBI diagnoses did not differ between those on no AT (21.25%) versus AT (21.61%; p = 0.418). Apixaban (15.7%; p < 0.001) and rivaroxaban (13.19%; p = 0.011) were associated with lower rates of TBI, and acetylsalicylic acid-clopidogrel was associated with a higher TBI rate (24.34%; p = 0.002) versus no AT. acetylsalicylic acid-clopidogrel was associated with a higher cranial surgery rate (2.9%; p = 0.006) versus no AT (1.96%), but surgery rates were similar for all other regimens. No regimen was associated with higher mortality.

CONCLUSION: In this large multicenter study, the intake of ATs in older patients with ground level falls was associated with inconsistent effects on risk of TBI and no significant increases in mortality, indicating that AT use may have negligible impact on patient clinical management. A large, confirmatory, prospective study is needed because the commonly held belief that ATs uniformly increase the risk of traumatic intracranial bleeding and mortality is not supported.

LEVEL OF EVIDENCE: Therapeutic/care management, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Fakhry SM, Morse JL, Garland JM, et al. Antiplatelet and anticoagulant agents have minimal impact on traumatic brain injury incidence, surgery, and mortality in geriatric ground level falls: A multi-institutional analysis of 33,710 patients. J Trauma Acute Care Surg. 2021. PMID: 33060534. doi:10.1097/TA.0000000000002985

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。